0001193125-24-018159.txt : 20240129 0001193125-24-018159.hdr.sgml : 20240129 20240129162854 ACCESSION NUMBER: 0001193125-24-018159 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240126 ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240129 DATE AS OF CHANGE: 20240129 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Harpoon Therapeutics, Inc. CENTRAL INDEX KEY: 0001708493 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 473458693 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38800 FILM NUMBER: 24574080 BUSINESS ADDRESS: STREET 1: 611 GATEWAY BOULEVARD, SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 443-7400 MAIL ADDRESS: STREET 1: 611 GATEWAY BOULEVARD, SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 8-K 1 d687029d8k.htm 8-K 8-K
false 0001708493 --12-31 0001708493 2024-01-26 2024-01-26

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 26, 2024

 

 

Harpoon Therapeutics, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

 

Delaware   001-38800   47-3458693

(State or Other Jurisdiction

of Incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

 

611 Gateway Boulevard

South San Francisco, California

   94080
(Address of Principal Executive Offices)   (Zip Code)

(650) 443-7400

(Registrant’s Telephone Number, Including Area Code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading
Symbol(s)

  

Name of each exchange
on which registered

Common stock, par value $0.0001 per share   HARP   The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 5.03

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On January 26, 2024, Harpoon Therapeutics, Inc. (the “Company”) filed a Certificate of Amendment to its Certificate of Designation of Preferences, Rights and Limitations of 8.000% Series A Redeemable Preferred Stock (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware to reflect the one-for-ten reverse stock split of the Company’s common stock effected by the Company on September 1, 2023.

The foregoing is only a summary of the terms of the Certificate of Amendment, does not purport to be complete and is qualified in its entirety by reference to the full text of the Certificate of Amendment, a copy of which is filed as Exhibit 3.1 hereto and incorporated by reference herein.

 

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit

No.

    Description
3.1    Certificate of Amendment to the Certificate of Designation of Preferences, Rights and Limitations of 8.000% Series A Redeemable Preferred Stock.
104    Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    Harpoon Therapeutics, Inc.
Date: January 29, 2024     By:  

/s/ Julie Eastland

      Julie Eastland
      President and Chief Executive Officer
 EX-3.1 2 d687029dex31.htm EX-3.1 EX-3.1

Exhibit 3.1

HARPOON THERAPEUTICS, INC.

AMENDMENT TO

CERTIFICATE OF DESIGNATION OF PREFERENCES,

RIGHTS AND LIMITATIONS

OF

8.000% SERIES A REDEEMABLE PREFERRED STOCK

HARPOON THERAPEUTICS, INC. (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, does hereby certify:

FIRST: The name of the Corporation is Harpoon Therapeutics, Inc.

SECOND: The date of filing of the original Designation of Preferences, Rights and Limitations of 8.000% Series A Redeemable Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware was March 23, 2023.

THIRD: That this Certificate of Amendment to the Certificate of Designation amends the definition of “Closing Price” in Section 1 thereof to read in its entirety as follows, which amendment was duly adopted on January 7, 2024 by the Board of Directors of the Corporation in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware and duly approved on January 24, 2024 by the Requisite Holders (as defined in the Certificate of Designation) of Series A Preferred Stock of the Corporation.

“Closing Price” means $7.251 (as equitably adjusted to reflect changes in the Corporation’s capitalization from reverse stock splits, stock splits, stock dividends or comparable events that occur after January 26, 2024).

FOURTH: This Certificate of Amendment to the Certificate of Designation shall be effective upon filing with the Secretary of State of the State of Delaware.

[SIGNATURE PAGE FOLLOWS]

IN WITNESS WHEREOF, Harpoon Therapeutics, Inc. has caused this Certificate of Amendment to be duly executed and acknowledged in its name and on its behalf by an authorized officer as of January 26, 2024.

 

HARPOON THERAPEUTICS, INC.

By:

  

/s/ Julie Eastland

 

Name: Julie Eastland

Title: President and Chief Executive Officer

 EX-101.SCH 3 harp-20240126.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 4 harp-20240126_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Ex Transition Period Entity Ex Transition Period EX-101.PRE 5 harp-20240126_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Document and Entity Information
Jan. 26, 2024
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001708493
Current Fiscal Year End Date --12-31
Document Type 8-K
Document Period End Date Jan. 26, 2024
Entity Registrant Name Harpoon Therapeutics, Inc.
Entity Incorporation State Country Code DE
Entity File Number 001-38800
Entity Tax Identification Number 47-3458693
Entity Address, Address Line One 611 Gateway Boulevard
Entity Address, City or Town South San Francisco
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94080
City Area Code (650)
Local Phone Number 443-7400
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common stock, par value $0.0001 per share
Trading Symbol HARP
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Entity Ex Transition Period false
EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 1 24 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.harpoontx.com//20240126/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d687029d8k.htm harp-20240126.xsd harp-20240126_lab.xml harp-20240126_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "d687029d8k.htm": { "nsprefix": "harp", "nsuri": "http://www.harpoontx.com/20240126", "dts": { "inline": { "local": [ "d687029d8k.htm" ] }, "schema": { "local": [ "harp-20240126.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd" ] }, "labelLink": { "local": [ "harp-20240126_lab.xml" ] }, "presentationLink": { "local": [ "harp-20240126_pre.xml" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2023": 3 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 25, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 24 }, "report": { "R1": { "role": "http://www.harpoontx.com//20240126/taxonomy/role/DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "duration_2024-01-26_to_2024-01-26", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d687029d8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "duration_2024-01-26_to_2024-01-26", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d687029d8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.harpoontx.com//20240126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.harpoontx.com//20240126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "terseLabel": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.harpoontx.com//20240126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.harpoontx.com//20240126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.harpoontx.com//20240126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.harpoontx.com//20240126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.harpoontx.com//20240126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.harpoontx.com//20240126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.harpoontx.com//20240126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.harpoontx.com//20240126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.harpoontx.com//20240126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://www.harpoontx.com//20240126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r7" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.harpoontx.com//20240126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "terseLabel": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.harpoontx.com//20240126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.harpoontx.com//20240126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.harpoontx.com//20240126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.harpoontx.com//20240126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "terseLabel": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.harpoontx.com//20240126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.harpoontx.com//20240126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.harpoontx.com//20240126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security 12b Title", "terseLabel": "Security 12b Title", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.harpoontx.com//20240126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "terseLabel": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.harpoontx.com//20240126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "terseLabel": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.harpoontx.com//20240126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.harpoontx.com//20240126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "terseLabel": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001193125-24-018159-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-24-018159-xbrl.zip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d687029d8k_htm.xml IDEA: XBRL DOCUMENT 0001708493 2024-01-26 2024-01-26 false 0001708493 --12-31 8-K 2024-01-26 Harpoon Therapeutics, Inc. DE 001-38800 47-3458693 611 Gateway Boulevard South San Francisco CA 94080 (650) 443-7400 false false false false Common stock, par value $0.0001 per share HARP NASDAQ true false